JP2023521167A5 - - Google Patents
Info
- Publication number
- JP2023521167A5 JP2023521167A5 JP2022562023A JP2022562023A JP2023521167A5 JP 2023521167 A5 JP2023521167 A5 JP 2023521167A5 JP 2022562023 A JP2022562023 A JP 2022562023A JP 2022562023 A JP2022562023 A JP 2022562023A JP 2023521167 A5 JP2023521167 A5 JP 2023521167A5
- Authority
- JP
- Japan
- Prior art keywords
- pharmaceutical composition
- cyclobenzaprine
- composition according
- item
- group
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2025172812A JP2025185159A (ja) | 2020-04-08 | 2025-10-14 | 性機能障害のシクロベンザプリン処置 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063007251P | 2020-04-08 | 2020-04-08 | |
| US63/007,251 | 2020-04-08 | ||
| PCT/US2021/026492 WO2021207561A1 (en) | 2020-04-08 | 2021-04-08 | Cyclobenzaprine treatment for sexual dysfunction |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025172812A Division JP2025185159A (ja) | 2020-04-08 | 2025-10-14 | 性機能障害のシクロベンザプリン処置 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023521167A JP2023521167A (ja) | 2023-05-23 |
| JP2023521167A5 true JP2023521167A5 (cg-RX-API-DMAC7.html) | 2024-04-22 |
| JP7780447B2 JP7780447B2 (ja) | 2025-12-04 |
Family
ID=75675042
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022562023A Active JP7780447B2 (ja) | 2020-04-08 | 2021-04-08 | 性機能障害のシクロベンザプリン処置 |
| JP2025172812A Pending JP2025185159A (ja) | 2020-04-08 | 2025-10-14 | 性機能障害のシクロベンザプリン処置 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2025172812A Pending JP2025185159A (ja) | 2020-04-08 | 2025-10-14 | 性機能障害のシクロベンザプリン処置 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20210315841A1 (cg-RX-API-DMAC7.html) |
| EP (1) | EP4132648B1 (cg-RX-API-DMAC7.html) |
| JP (2) | JP7780447B2 (cg-RX-API-DMAC7.html) |
| CN (1) | CN115803088B (cg-RX-API-DMAC7.html) |
| AU (1) | AU2021253592A1 (cg-RX-API-DMAC7.html) |
| CA (1) | CA3179754A1 (cg-RX-API-DMAC7.html) |
| WO (1) | WO2021207561A1 (cg-RX-API-DMAC7.html) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20240415789A1 (en) * | 2021-10-06 | 2024-12-19 | Tonix Pharmaceuticals Holding Corp. | Cyclobenzaprine for treatment or prevention of sexual dysfunction associated with mental health conditions in female patients |
| US12370198B2 (en) | 2022-07-08 | 2025-07-29 | La Pharmatech Inc | Pharmaceutical compositions and methods for treating psychiatric disorders |
| KR20250086333A (ko) * | 2023-12-06 | 2025-06-13 | 삼진제약주식회사 | 약학적 제제 및 이의 제조방법 |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI242011B (en) | 1997-03-31 | 2005-10-21 | Eisai Co Ltd | 1,4-substituted cyclic amine derivatives |
| AR025110A1 (es) * | 1999-08-13 | 2002-11-06 | Vela Pharmaceuticals Inc | Metodos y composiciones para tratar o prevenir alteraciones del sueno y enfermedades asociadas usando dosis muy bajas de ciclobenzaprina |
| US6855324B2 (en) * | 2000-11-20 | 2005-02-15 | Adrian Sandler | Therapeutic placebo enhancement of commonly-used medications |
| JP2008540673A (ja) * | 2005-05-19 | 2008-11-20 | ベーリンガー インゲルハイム インターナショナル ゲゼルシャフト ミット ベシュレンクテル ハフツング | 薬剤誘発性性機能不全の治療方法 |
| PT2501234T (pt) * | 2009-11-20 | 2017-12-13 | Tonix Pharma Holdings Ltd | Métodos e composições para o tratamento de sintomas associados com distúrbios de stress pós-traumático utilizando ciclobenzaprina |
| EA201391459A1 (ru) | 2011-04-04 | 2014-03-31 | С1 Биофарма, Инк. | Режимы лечения |
| SI2861223T1 (sl) * | 2012-06-15 | 2023-01-31 | Tonix Pharma Holdings Limited | Sestavki in postopki za transmukozalno absorpcijo |
| MY196014A (en) * | 2013-03-15 | 2023-03-06 | Tonix Pharmaceuticals Inc | Eutectic Formulations of Cyclobenzaprine Hydrochloride and Amitriptyline Hydrochloride |
| SG10201902203VA (en) * | 2014-09-18 | 2019-04-29 | Tonix Pharma Holdings Ltd | Eutectic formulations of cyclobenzaprine hydrochloride |
| JP2018512450A (ja) * | 2015-03-19 | 2018-05-17 | ウェンディ アン エプスタインEPSTEIN, Wendy Anne | 女性の性的障害を治療するための化合物及び剤型 |
| MX2019005851A (es) * | 2016-11-22 | 2019-10-07 | Alkalidx Inc | Terapias para el tratamiento de afecciones hipocalemicas e ineficaces a lidocaina. |
| BR112020011345A2 (pt) | 2017-12-11 | 2020-11-17 | Tonix Pharma Holdings Limited | tratamento com ciclobenzaprina para agitação, psicose e declínio cognitivo na demência e condições neurodegenerativas |
| EP3840738A1 (en) | 2018-08-20 | 2021-06-30 | Tonix Pharma Holdings Limited | Methods of treating acute stress disorder and posttraumatic stress disorder |
| US11337937B2 (en) * | 2018-08-27 | 2022-05-24 | ReJoy | TARR receptor agonists for sexual dysfunction |
-
2021
- 2021-04-08 JP JP2022562023A patent/JP7780447B2/ja active Active
- 2021-04-08 EP EP21721779.3A patent/EP4132648B1/en active Active
- 2021-04-08 WO PCT/US2021/026492 patent/WO2021207561A1/en not_active Ceased
- 2021-04-08 CA CA3179754A patent/CA3179754A1/en active Pending
- 2021-04-08 US US17/226,058 patent/US20210315841A1/en active Pending
- 2021-04-08 CN CN202180040673.8A patent/CN115803088B/zh active Active
- 2021-04-08 AU AU2021253592A patent/AU2021253592A1/en active Pending
-
2025
- 2025-10-14 JP JP2025172812A patent/JP2025185159A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2025185159A (ja) | 性機能障害のシクロベンザプリン処置 | |
| JP5991988B2 (ja) | 子宮内膜基底層の剥脱に関する疼痛の治療 | |
| JP4880031B2 (ja) | 全般性不安障害の処置に用いる医薬を製造するためのアゴメラチンの使用 | |
| KR100706727B1 (ko) | 중증 심부전의 치료방법 및 이를 위한 약제 | |
| JP2002523366A (ja) | ドーパミン再取込みインヒビターを含有する組成物及びその使用方法 | |
| TW201936567A (zh) | 發炎性疾病或骨病之預防或治療劑及醫藥組成物 | |
| JP2008540672A (ja) | 病状に起因する性的機能不全の治療方法 | |
| US20220160683A1 (en) | Nk-1 antagonist compositions and methods for use in treating depression | |
| JP2020523355A (ja) | 肉腫を処置することへの使用のためのチノスタムスチン | |
| JP5298334B2 (ja) | 性機能障害を治療する方法 | |
| CN1262622A (zh) | 调节人性反应的联合治疗 | |
| US8101580B2 (en) | Therapeutic agent for irritable bowel syndrome | |
| CN102781437B (zh) | 阿戈美拉汀在得到预定治疗强迫性障碍(ocd)的药物中的用途 | |
| CN101194901A (zh) | 阿戈美拉汀在制备用于治疗Smith-Magenis综合征的药物中的用途 | |
| Marinho et al. | Behçet's syndrome: literature review and clinical case report | |
| HK40090080B (en) | Cyclobenzaprine treatment for sexual dysfunction | |
| HK40090080A (zh) | 性功能障碍的环苯扎林治疗 | |
| JPWO2020080451A1 (ja) | 糖尿病腎症における腎線維化抑制剤 | |
| JP2004529850A (ja) | 性機能不全の処置および防止のための方法および組成物 | |
| US10022389B2 (en) | Prophylactic or therapeutic drug for constipation | |
| US20240415789A1 (en) | Cyclobenzaprine for treatment or prevention of sexual dysfunction associated with mental health conditions in female patients | |
| US20240238290A1 (en) | Use of complement factor d inhibitor for treatment of generalized myasthenia gravis | |
| WO2025245066A1 (en) | Compositions and methods for affecting weight loss, weight management, sexual disorders, well-being, self-esteem, and/or self-confidence | |
| EP4419097A1 (en) | Use of complement factor d inhibitor for treatment of lupus nephritis and immunoglobulin a nephropathy | |
| CN118922187A (zh) | 体重减轻和保持骨骼肌量的方法 |